Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

This study is ongoing, but not recruiting participants.

Study NCT00478205 Information provided by Eisai Inc.

First Received: May 22, 2007 Last Updated: August 26, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Alzheimer's Disease

Additional conditions recognized in this trial

Alzheimer Disease

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Donepezil

More general drug interventions related to this trial

Sponsors listed in this trial

Eisai Inc.
Eisai Limited